Precision health intelligence · India

A Deeper Measure of Being Well.

Biology. Lifestyle. Environment. Trajectory.

See what's coming → How it works
Scroll

The Gap

Standard reports give you numbers.
Phenotype gives you context.

Every blood report in India hands you a column of numbers checked against reference ranges derived almost entirely from Western cohort data. The doctor has seven minutes. The report goes in a drawer. The biology it represents — the cross-system patterns, the subclinical trajectories, the population-specific signals — goes unread.

The problem is not the numbers. It is what is being done with them. A haemoglobin of 12 g/dL means something different for a 26-year-old Indian woman with a specific lipid pattern and a history of low energy than it does for the Western population it was benchmarked against. Standard reporting cannot tell you this. Phenotype can.

53%
of Indian women aged 15–49 are anaemic — a further 31.5% carry latent iron deficiency that standard tests miss entirely (NFHS-5, 2019–21)
9.4×
higher adjusted odds for Indians having atherogenic TG/HDL ratio vs white populations — independent of obesity or body weight (PubMed, 2011)
2×
higher T2DM prevalence in South Asians vs non-Hispanic whites — driven by insulin resistance patterns Western risk calculators are not built to detect

What We Do

Biomarker intelligence,
built on systems biology.

01

Blood Panel Analysis

Upload your standard blood report. Phenotype extracts and structures every marker — CBC, metabolic panel, lipids, thyroid, iron studies, and beyond — and reads each value within its clinical and population context.

02

Systems Interpretation

Biomarkers do not exist in isolation. Phenotype maps interactions across biological pathways — how your HbA1c relates to your lipid pattern, what your ESR signals in that metabolic context, what the cross-system picture means together.

03

Indian Cohort Calibration

Reference ranges matter. Phenotype uses thresholds calibrated for Indian and South Asian populations, where metabolic risk, inflammatory patterns, and disease trajectories manifest differently than the populations most clinical guidelines were built on.

How It Works

Simple process.
Serious science.

01

Upload your report

Upload your blood report PDF directly, right here — no separate tool, no manual data entry on your end.

02

Phenotype interprets

Your markers are processed through Phenotype's proprietary model — built in-house and calibrated from the ground up to Indian biological reference ranges, not adapted from Western defaults — to surface what is clinically meaningful, not just what is numerically out of range.

03

You receive your biological portrait

A structured, evidence-grounded interpretation delivered to your inbox — with the science intact, the jargon removed, and every finding traceable to its clinical basis. Not a diagnosis. A biological portrait.

Why India

Precision requires context.

South Asians develop insulin resistance and cardiovascular risk at lower body weight thresholds than Western populations — a difference most health tools ignore entirely because it was never part of the cohort data they were built on.

The thin-fat Indian phenotype — normal BMI with disproportionately high visceral adiposity — drives metabolic dysfunction through mechanisms that standard anthropometric measures systematically miss.

Vitamin D deficiency, PCOS, thyroid dysfunction, and metabolic syndrome each present with distinct epidemiological profiles in Indian cohorts, requiring population-specific interpretation logic to read correctly.

India lacks community-level precision health infrastructure. Phenotype is being built to address this gap — not as a workaround, but as a deliberate research and clinical translation effort grounded in Indian cohort data.

"The risk thresholds most laboratories use were derived from populations that look nothing like the patients I treat."

— Clinician, Pune

The Research Layer

India carries a biological signature.
When it shifts, it rewires.

Indian biology is not a deviation from a Western norm — it is a distinct phenotype. The thin-fat body composition, the atherogenic lipid signature, the inflammatory baseline, the iron dynamics — these are not individual risk factors. They are a biological identity. When that identity is under chronic stress, its systems begin to rewire. The rewiring is not random. It follows patterns that are detectable in blood data years before clinical thresholds are crossed. This is what Phenotype is built to read. And this is what computational biology, applied at population scale and calibrated to Indian biology, makes possible for the first time.

01

Type 2 Diabetes

101 million diabetics — India leads globally

India has the highest absolute diabetic burden in the world. The phenotypic signature that precedes T2DM — atherogenic dyslipidaemia, rising glycaemic trajectory, early insulin resistance — is detectable years before diagnosis. HbA1c at 5.5% is not normal. It is the window.

Phenotype tracks · HbA1c trajectory · TG/HDL ratio · fasting insulin pattern

02

Cardiovascular Disease

Leading cause of death — rising at younger ages

CVD is India's largest killer and is appearing at younger ages than Western epidemiological models predict. The thin-fat phenotype drives cardiovascular risk at BMI thresholds where Western populations show no such signal. The lipid pattern is different. The risk calculator has to be too.

Phenotype tracks · atherogenic dyslipidaemia · Chol/HDL ratio · VLDL elevation

03

Metabolic Cancers

Breast, colorectal, pancreatic — fastest rising

The metabolic-inflammatory-oncogenic axis is a documented pathway, not a hypothesis. Chronic hyperinsulinaemia, visceral adiposity, and low-grade inflammation create the biological milieu that oncogenic signalling requires. The upstream signal is metabolic. It is present years before the clinical presentation.

Phenotype tracks · ESR-CRP pattern · insulin resistance · inflammatory load

04

Fatty Liver Disease

38% urban prevalence — largely undetected

Non-alcoholic fatty liver disease affects an estimated 38% of urban Indians — a silent epidemic driven by the same atherogenic lipid pattern that drives cardiovascular and metabolic risk. VLDL overproduction and hepatic insulin resistance are visible in blood panels before imaging detects anything.

Phenotype tracks · VLDL · liver enzyme pattern · TG/HDL dysregulation

05

Chronic Kidney Disease

Accelerating as downstream metabolic consequence

CKD is rising as the downstream consequence of India's metabolic disease burden. Its progression is trackable through the inflammatory and metabolic signals that precede it — signals that accumulate quietly in blood data for years before renal function is measurably compromised.

Phenotype tracks · metabolic burden index · inflammatory trajectory · creatinine trend

Computational Biology + Precision Medicine

"A single biomarker is a data point. A cross-system pattern is a signal. Computational biology is what makes it possible to read that signal across populations — to identify not just what is happening in the body right now, but which trajectory it is on. This is what precision medicine means when it is applied at population scale rather than as a clinical luxury reserved for the few."

Proprietary · In Validation

Model 1 — The Phenotype Research Engine

Model 1 is Phenotype's own clustering and scoring pipeline, built end-to-end in-house rather than adapted from an off-the-shelf risk calculator. Every marker panel is normalised against Indian reference ranges, clustered against a healthy population baseline, and projected onto validated disease axes — surfacing where a person's biology is trending, not just where a single value sits today.

How Phenotype sustains itself

Consumer Layer

Indian users understand their biology

Blood reports interpreted through an Indian biological lens. Delivered as a structured, evidence-grounded portrait. The product generates revenue. That revenue funds the research.

generates data · funds research infrastructure
↔
mutually
reinforcing

Research Layer

Community data builds Indian phenotypic infrastructure

Anonymised, consented report data builds the community-level biomarker database India lacks. Phenotypic clusters validated against clinical outcomes. The research makes the product more accurate.

validates clusters · improves accuracy · enables grants

Behind The Model

A glimpse into
the work going on.

Model 1 isn't a mockup — it's being built and validated in real time, on real sequencing data and real clustering runs.

Volcano plot of differential protein expression on a lab laptop screen

Differential Expression

Significant proteins mapped by fold-change and significance — the kind of signal Model 1 is built to translate into a readable phenotype.

FastQC per-base sequence quality report on a laptop screen

Quality Control

Per-base sequence quality checked before any dataset enters the pipeline — precision starts with clean data.

Late evening at the research campus

After Hours

The work doesn't run on lab hours. Most of Model 1 gets built after everyone else has gone home.

Get Started

Start with your biology.
Coming soon.

A structured biological interpretation of your blood report — calibrated for Indian biology, not Western approximations of it.

Coming Soon

The upload-and-analysis pipeline is currently in development. Check back soon to submit your report.

This platform provides biological interpretation, not medical diagnosis. Phenotype does not replace clinical consultation. Your uploaded report and contact details are stored securely to prepare your analysis and are not shared with third parties.